Xenetic Biosciences (XBIO) Net Margin (2011 - 2026)
Xenetic Biosciences' Net Margin was -140.73% in Q2 2026, down 23.99 percentage points from -116.75% a year earlier and down 84.18 percentage points from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) Net Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Xenetic Biosciences' Net Margin was -75.91% through Jun 30, 2026, up 50.13 percentage points year-over-year; for FY2025, it came in at -90.07%, up 68.32 percentage points from FY2024.
- Net Margin has now increased for six consecutive years, with a five-year change of +2403.04 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -158.39% in FY2024 (+4.39 pp), -162.78% in FY2023 (+221.09 pp), -383.87% in FY2022 (+102.49 pp) and -486.36% in FY2021 (+2006.75 pp).
- The Q2 2026 figure marks the lowest quarterly Net Margin since Q1 2025.
- Compared with a year earlier, Net Margin was higher in seven of the last eight quarters, with an average year-over-year change of +54.23 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q3 2021 (a gain of 6134.50 percentage points); the worst was Q2 2022 (a drop of 256.47 percentage points).
- Per Business Quant data, XBIO's Net Margin in the three quarters before Q2 2026 was -56.56% (Q1 2026), -75.57% (Q4 2025) and -49.66% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.40 Bn | 1,140.99 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 642.90 Bn | 561.42 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 375.88 Bn | 330.26 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 302.81 Bn | 266.80 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 268.58 Bn | 242.27 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 242.38 Bn | 197.78 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 193.63 Bn | 167.83 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | -1.65% |
| 10 | Xenetic Biosciences | 4.57 Mn | -21.26 Mn | - | -140.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -140.73% |
| Mar 31, 2026 | -56.56% |
| Dec 31, 2025 | -75.57% |
| Sep 30, 2025 | -49.66% |
| Jun 30, 2025 | -116.75% |
| Mar 31, 2025 | -152.23% |
| Dec 31, 2024 | -162.53% |
| Sep 30, 2024 | -71.09% |
| Jun 30, 2024 | -175.38% |
| Mar 31, 2024 | -233.96% |
| Dec 31, 2023 | -174.34% |
| Sep 30, 2023 | -172.71% |
| Jun 30, 2023 | -161.44% |
| Mar 31, 2023 | -141.38% |
| Dec 31, 2022 | -304.44% |
| Sep 30, 2022 | -194.09% |
| Jun 30, 2022 | -641.26% |
| Mar 31, 2022 | -409.68% |
| Dec 31, 2021 | -553.72% |
| Sep 30, 2021 | -386.77% |
API Access
Xenetic Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();